Detalles de la búsqueda
1.
Risk of reactivation of hepatitis B virus (HBV) and tuberculosis (TB) and complications of hepatitis C virus (HCV) following Tocilizumab therapy: A systematic review to inform risk assessment in the COVID era
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21254128
Resultados
1 -
1
de 1
1
Próxima >
>>